查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555507

吸入抗生素市場，按產品類型、應用、配銷通路、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Inhaled Antibiotics Market, By Product Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 345 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年吸入抗生素市場規模為15.3212億美元，2024年至2032年複合年成長率為6.5%。

吸入抗生素市場-市場動態

包括氣喘和慢性阻塞性肺病（COPD）在內的呼吸系統疾病的盛行率不斷上升，預計將推動市場需求。吸入抗生素在治療經常與呼吸道疾病相關的慢性細菌感染方面發揮著至關重要的作用，例如囊性纖維化中的銅綠假單胞菌和慢性阻塞性肺病患者的其他持續性感染。根據健康指標與評估研究所的數據，2019 年，慢性呼吸道疾病是第三大死因，造成400 萬人死亡（95% 不確定性區間為3.6-430 萬人），影響約4.546 億人（範圍為36-430 萬人）。

增強肺部藥物輸送的新配方和設備的推出正在創造更多的市場機會。然而，高成本和可近性問題可能會對市場成長構成挑戰。

吸入抗生素市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 6.5% 左右的複合年成長率成長

根據產品類型細分，預計氣霧劑將在 2023 年顯示最大的市場佔有率

根據應用細分，肺炎是 2023 年的領先產品類型

根據配銷通路細分，醫院藥房是 2023 年領先的產品類型

按地區分類，北美是 2023 年的主要收入來源

吸入抗生素市場-細分分析：

全球吸入抗生素市場根據產品類型、應用、配銷通路和地區進行細分。

根據產品類型，市場分為三個部分：氣霧劑、乾粉和噴霧製劑。氣霧劑領域引領市場。在慢性呼吸道疾病發病率上升和給藥技術創新的推動下，吸入抗生素產業以及氣霧劑給藥領域正在經歷成長。

根據應用，市場分為兩個部分：肺炎、氣喘、支氣管炎和其他。肺炎在市場上佔據領先地位。吸入抗生素領域對於肺炎的治療變得越來越重要，特別是在某些患者人口統計和傳統口服或靜脈注射抗生素可能效果較差的情況下。

根據配銷通路，市場分為兩個部分：醫院藥房、零售藥房和其他。醫院藥房在市場上佔據主導地位。吸入抗生素產業與醫院藥局密切相關，因為這些藥物在複雜呼吸道感染的治療中發揮著至關重要的作用，尤其是在醫院環境中。

吸入抗生素市場 - 地理洞察

市場地域廣闊，涵蓋北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些領域根據對商業活動做出貢獻的國家進一步分類。北美引領市場，主要是因為抗生素抗藥性問題日益嚴重。抗生素抗藥性細菌（尤其是影響呼吸系統的細菌）的發生率不斷上升，刺激了對吸入抗生素的需求。這些藥物對於治療抗藥性感染至關重要，尤其是在慢性阻塞性肺病 (COPD) 和囊性纖維化等疾病中。美國疾病管制與預防中心 (CDC) 已將抗菌素抗藥性 (AR) 確定為一項重大的全球公共衛生挑戰，美國每年報告超過 280 萬例抗菌素抗藥性感染。

在先進的醫療保健系統和監管框架的支持下，歐洲呈現持續成長的勢頭。與此同時，在醫療保健投資增加和疾病盛行率上升的推動下，亞太地區正在經歷快速發展。

吸入抗生素市場-競爭格局：

吸入抗生素市場的競爭格局受到多種因素的影響，包括產品的有效性、技術進步、監管批准、定價策略和整體市場表現。為了在這個動態環境中保持競爭優勢，企業需要不斷創新和適應。重點是開發獨特的製劑或遞送機制，以提供增強的性能或滿足未滿足的醫療需求。擁有完善的全球分銷網路和戰略合作夥伴關係的組織有能力獲得更大的市場滲透率。

最新進展：

2024年7月，臨床階段生物技術公司Armata Pharmaceuticals, Inc.宣布，已完成吸入AP-PA02治療非傳染性發燒和慢性肺銅綠假單胞菌患者的Tailwind 2期臨床研究的入組。胞菌）感染。研究的重點是針對對抗生素抗藥性且難以治療的細菌感染的病原體特異性噬菌體療法。

目錄

第 1 章：吸入抗生素市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的吸入抗生素市場片段
    • 吸入抗生素市場片段（依應用）
    • 按配銷通路分類的吸入抗生素市場片段
    • 按國家/地區分類的吸入抗生素市場片段
    • 按地區分類的吸入抗生素市場片段
  • 競爭洞察

第 3 章：吸入抗生素主要市場趨勢

  • 吸入抗生素市場促進因素
    • 市場促進因素的影響分析
  • 吸入抗生素市場限制
    • 市場限制影響分析
  • 吸入抗生素市場機會
  • 吸入抗生素市場未來趨勢

第 4 章：吸入抗生素產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：吸入抗生素市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：吸入抗生素市場格局

  • 2023 年吸入性抗生素市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：吸入抗生素市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 氣霧劑
    • 乾粉
    • 配方
    • 噴

第 8 章：吸入抗生素市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 肺炎
    • 氣喘
    • 支氣管炎
    • 其他

第 9 章：吸入抗生素市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥房
    • 其他

第 10 章：吸入抗生素市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美吸入抗生素主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲吸入抗生素主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區吸入抗生素主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲吸入抗生素主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲吸入抗生素主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 吸入抗生素產業

  • 競爭儀表板
  • 公司簡介
    • Gilead Sciences
    • Aradigm
    • Lupin Ltd
    • Polyphor
    • Insmed Incorporated
    • Pharmaero
    • Savara Pharmaceuticals
    • Joincare Pharmaceutical Group
    • Pharmaxis Ltd
    • Teva Pharamceuticals
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3642

REPORT HIGHLIGHT

Inhaled Antibiotics Market size was valued at USD 1,532.12 million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Inhaled antibiotics are therapeutic agents administered directly to the lungs through inhalation, specifically aimed at treating respiratory infections. These medications are frequently utilized in the management of chronic respiratory diseases, including cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). The use of inhaled antibiotics is essential in the treatment of these chronic conditions, providing focused therapy and enhancing the overall quality of life for patients.

Inhaled Antibiotics Market- Market Dynamics

The increasing prevalence of respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), is anticipated to drive market demand. Inhaled antibiotics play a crucial role in the treatment of chronic bacterial infections frequently associated with respiratory conditions, such as Pseudomonas aeruginosa in cystic fibrosis and other persistent infections in COPD patients. According to the Institute for Health Metrics and Evaluation, in 2019, chronic respiratory diseases were the third leading cause of death, accounting for 4.0 million fatalities (with a 95% uncertainty interval of 3.6-4.3 million) and affecting approximately 454.6 million individuals (ranging from 417.4 to 499.1 million) worldwide.

The introduction of new formulations and devices that enhance drug delivery to the lungs is creating additional market opportunities. However, high costs and accessibility issues may pose challenges to market growth.

Inhaled Antibiotics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)

Based on Product Type segmentation, Aerosol was predicted to show maximum market share in the year 2023

Based on Application segmentation, Pneumonia was the leading Product Type in 2023

Based on Distribution Channel segmentation, Hospital Pharmacy was the leading Product Type in 2023

Based on region, North America was the leading revenue generator in 2023

Inhaled Antibiotics Market- Segmentation Analysis:

The Global Inhaled Antibiotics Market is segmented based on Product Type, Application, Distribution Channel, and Region.

The market is classified into three segments according to Product Type: Aerosol, Dry Powder, and Spray Formulation. The Aerosol segment leads the market. The inhaled antibiotics sector, along with the aerosol drug delivery segment, is experiencing growth driven by the rising incidence of chronic respiratory diseases and innovations in drug delivery technologies.

The market is classified into two segments according to application: Pneumonia, Asthma, Bronchitis, and Others. Pneumonia holds a leading position in the market. The inhaled antibiotics sector is becoming increasingly significant for the treatment of pneumonia, particularly in certain patient demographics and situations where conventional oral or intravenous antibiotics may prove less effective.

The market is categorized into two segments according to the Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Others. Hospital Pharmacy holds a dominant position within the market. The inhaled antibiotics sector is notably intertwined with hospital pharmacies, as these medications play a vital role in the treatment of intricate respiratory infections, especially in hospital environments.

Inhaled Antibiotics Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further categorized based on the countries contributing to business activities. North America leads the market, primarily due to the rising issue of antibiotic resistance. The growing incidence of antibiotic-resistant bacteria, particularly those impacting the respiratory system, fuels the demand for inhaled antibiotics. These medications are essential for managing resistant infections, especially in conditions such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The Centers for Disease Control and Prevention (CDC) have identified antimicrobial resistance (AR) as a critical global public health challenge, with over 2.8 million antimicrobial-resistant infections reported annually in the United States.

Europe exhibits consistent growth, bolstered by advanced healthcare systems and regulatory frameworks. Meanwhile, the Asia-Pacific region is experiencing rapid development, driven by increased healthcare investments and a rise in disease prevalence.

Inhaled Antibiotics Market- Competitive Landscape:

The competitive landscape of the inhaled antibiotics market is influenced by several factors, including the effectiveness of products, advancements in technology, regulatory approvals, pricing strategies, and overall market presence. To sustain a competitive advantage in this dynamic environment, companies are required to engage in continuous innovation and adaptation. Emphasis is placed on developing distinctive formulations or delivery mechanisms that provide enhanced performance or fulfil unmet medical needs. Organizations with well-established global distribution networks and strategic partnerships are positioned to attain greater market penetration.

Recent Developments:

In July 2024, A clinical-stage biotechnology company, Armata Pharmaceuticals, Inc., announced that it has completed enrollment in its Tailwind Phase 2 clinical study of inhaled AP-PA02 for patients with non-communicable fever and chronic pulmonary Pseudomonas aeruginosa (P. aeruginosa) infection. The study focuses on pathogen-specific bacteriophage therapeutics for bacterial infections that are resistant to antibiotics and difficult to treat.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INHALED ANTIBIOTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Gilead Sciences
  • Aradigm
  • Lupin Ltd
  • Polyphor
  • Insmed Incorporated
  • Pharmaero
  • Savara Pharmaceuticals
  • Joincare Pharmaceutical Group
  • Pharmaxis Ltd
  • Teva Pharmaceuticals
  • Others

GLOBAL INHALED ANTIBIOTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Aerosol
  • Dry Powder
  • Formulation
  • Spray

GLOBAL INHALED ANTIBIOTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Pneumonia
  • Asthma
  • Bronchitis
  • Others

GLOBAL INHALED ANTIBIOTICS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

GLOBAL INHALED ANTIBIOTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Inhaled Antibiotics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Inhaled Antibiotics Market Snippet by Product Type
    • 2.1.2. Inhaled Antibiotics Market Snippet by Application
    • 2.1.3. Inhaled Antibiotics Market Snippet by Distribution Channel
    • 2.1.4. Inhaled Antibiotics Market Snippet by Country
    • 2.1.5. Inhaled Antibiotics Market Snippet by Region
  • 2.2. Competitive Insights

3. Inhaled Antibiotics Key Market Trends

  • 3.1. Inhaled Antibiotics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Inhaled Antibiotics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Inhaled Antibiotics Market Opportunities
  • 3.4. Inhaled Antibiotics Market Future Trends

4. Inhaled Antibiotics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Inhaled Antibiotics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Inhaled Antibiotics Market Landscape

  • 6.1. Inhaled Antibiotics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Inhaled Antibiotics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Aerosol
    • 7.1.3. Dry Powder
    • 7.1.4. Formulation
    • 7.1.5. Spray

8. Inhaled Antibiotics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Pneumonia
    • 8.1.3. Asthma
    • 8.1.4. Bronchitis
    • 8.1.5. Others

9. Inhaled Antibiotics Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacy
    • 9.1.3. Retail Pharmacy
    • 9.1.4. Others

10. Inhaled Antibiotics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Inhaled Antibiotics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Inhaled Antibiotics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Inhaled Antibiotics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Inhaled Antibiotics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Inhaled Antibiotics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Inhaled Antibiotics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Gilead Sciences
    • 11.2.2. Aradigm
    • 11.2.3. Lupin Ltd
    • 11.2.4. Polyphor
    • 11.2.5. Insmed Incorporated
    • 11.2.6. Pharmaero
    • 11.2.7. Savara Pharmaceuticals
    • 11.2.8. Joincare Pharmaceutical Group
    • 11.2.9. Pharmaxis Ltd
    • 11.2.10. Teva Pharamceuticals
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us